Detailed Analysis of the Scope and Claims of United States Patent 10,736,896
Introduction
United States Patent 10,736,896, issued on August 11, 2020, is a significant patent in the pharmaceutical sector, particularly focusing on novel substituted 5-fluoro-1H-pyrazolopyridines. This patent is assigned to ADVERIO PHARMA GMBH and involves a team of inventors including Markus Follmann, Johannes-Peter Stasch, and others.
Background and Context
The patent is part of a series of continuations and divisions of earlier applications, indicating a long-standing research and development effort. The earliest application in this chain dates back to November 24, 2014, and the patent has evolved through several continuations and divisions since then[4].
Scope of the Patent
The patent covers novel substituted 5-fluoro-1H-pyrazolopyridines, which are compounds used in the treatment and/or prophylaxis of various diseases, particularly cardiovascular disorders. Here are the key aspects of the scope:
Chemical Compounds
The patent describes the synthesis and use of substituted 5-fluoro-1H-pyrazolopyridines. These compounds are designed to have specific pharmacological properties, making them useful for treating cardiovascular conditions[4].
Therapeutic Uses
The compounds are intended for the treatment and/or prophylaxis of diseases, with a particular focus on cardiovascular disorders. This includes conditions such as heart failure, hypertension, and other related cardiovascular diseases[4].
Manufacturing Processes
The patent also includes processes for the preparation of these compounds, which is crucial for their commercial production and use in medicaments[4].
Claims of the Patent
The patent includes several claims that define the legal boundaries of the invention.
Independent Claims
The patent has a set of independent claims that protect the novel compounds and their uses. These claims are broad and cover the core aspects of the invention, including the chemical structure of the compounds and their therapeutic applications[4].
Dependent Claims
In addition to the independent claims, there are dependent claims that further specify the scope of the invention. These claims often detail specific aspects of the compounds, such as particular substituents or methods of use[4].
Claim Characteristics and Value
Research on patent claims suggests that the number and type of claims can influence the value of a patent. Here are some insights relevant to this patent:
Number of Claims
The patent has a moderate number of claims, which is typical for pharmaceutical patents. A higher number of claims can indicate more inventive contributions and a greater willingness to invest in the patent, potentially increasing its value[3].
Type of Claims
The patent includes both product claims and method claims. Product claims, which protect the novel compounds themselves, generally offer broader legal protection and are often more valuable than method claims[3].
Claim Formulation
The way claims are formulated can also impact their value. Functional claims, which describe the invention based on its function rather than its structure, might be more valuable as they offer broader protection[3].
Patent Landscape
The patent landscape surrounding US 10,736,896 is complex and involves several related patents and applications.
Related Patents
There are numerous related patents cited in the document, indicating a rich history of research and development in this area. These include patents from the same inventors and assignees, as well as patents from other entities working on similar compounds and therapeutic uses[4].
Exclusivity and Patent Term
The patent term for US 10,736,896 is subject to the standard 20-year term from the date of filing, but it can be adjusted based on various factors such as patent infringement litigation or the development of new formulations. Additionally, the patent may benefit from exclusivity periods granted by the FDA, which can run concurrently with the patent term[2].
Industry Impact
This patent has significant implications for the pharmaceutical industry, particularly in the treatment of cardiovascular diseases.
Market Potential
The compounds covered by this patent have the potential to address a large and growing market for cardiovascular treatments. The novelty and therapeutic efficacy of these compounds could provide a competitive edge in the market[4].
Research and Development
The issuance of this patent encourages further research and development in the field. It sets a benchmark for innovation and may prompt other researchers and companies to explore similar or related compounds[4].
Key Takeaways
- Novel Compounds: The patent covers novel substituted 5-fluoro-1H-pyrazolopyridines with specific pharmacological properties.
- Therapeutic Uses: The compounds are primarily for treating cardiovascular disorders.
- Claim Structure: The patent includes independent and dependent claims, with a focus on product claims for broader protection.
- Patent Landscape: The patent is part of a complex landscape involving multiple related patents and applications.
- Industry Impact: The patent has significant potential for market impact and further research in cardiovascular treatments.
FAQs
Q: What is the primary focus of United States Patent 10,736,896?
A: The primary focus is on novel substituted 5-fluoro-1H-pyrazolopyridines for the treatment and/or prophylaxis of cardiovascular disorders.
Q: Who are the inventors of this patent?
A: The inventors include Markus Follmann, Johannes-Peter Stasch, and several other researchers from ADVERIO PHARMA GMBH.
Q: What is the significance of the claim structure in this patent?
A: The claim structure includes both independent and dependent claims, with a focus on product claims to provide broader legal protection.
Q: How does this patent fit into the broader patent landscape?
A: It is part of a series of related patents and applications, indicating a long-standing research effort in this area.
Q: What is the potential market impact of this patent?
A: The patent has significant potential for market impact, particularly in the treatment of cardiovascular diseases, due to the novelty and therapeutic efficacy of the compounds.
Cited Sources
- United States Patent and Trademark Office. United States Patent 11,439,642 B2. Retrieved from https://patentimages.storage.googleapis.com/b3/8d/44/6826e255721d51/US11439642.pdf
- Drugs.com. Generic Verquvo Availability. Retrieved from https://www.drugs.com/availability/generic-verquvo.html
- TUE Research Portal. Examining the relation between patent value and patent claims. Retrieved from https://pure.tue.nl/ws/portalfiles/portal/46937839/642246-1.pdf
- United States Patent and Trademark Office. United States Patent 10,736,896. Retrieved from https://patentimages.storage.googleapis.com/e0/ad/0a/18bdc231ed6e34/US10736896.pdf
